Introduction
============

Scorpion bites are one of the most important environmental health hazards in Iran. The clinical manifestations of scorpion envenomation can be a challenge for emergency physicians since they are diverse, ranging from mild burning sensations at the sting site to critical fatal conditions\[[@B1]\].Recognition of clinical presentations and complications of scorpion sting are invaluable as it could shed light on the way to therapeutic strategies. Scorpion bites often have dangerous consequences, including death due to cardio-circulatory failure, including acute pulmonary edema and also in rare cases cerebral vascular accidents. Another manifestation is coagulative disorder which is disseminated commonly. These may be the result of a venom direct action or consequence of hemodynamic and blood coagulation disorders. Rare ocular manifestations of scorpion bites include transient blindness, cerebral blindness, and Bilateral Optic Neuropathy (BON) \[[@B2]-[@B4]\].Herein, we present a case of macular Branch Retinal Vein Occlusion (BRVO) after the scorpion bite in the periocular region. To the best of our knowledge, this is the first report of periocular scorpion bite presented as BRVO.

Case Report
===========

A 45-year-old woman referred to the emergency room of our ophthalmology center with the chief complaint of abrupt vision loss and periorbital edema in her right eye. The patient reported that she was stung by a scorpion on her right eyebrow 2 days prior to admission and she had not received anti-venom. The patient brought the dead scorpion picture, and the species was confirmed by an entomologist as yellow scorpion (Mesobuthus Eupeus). The patient reported that she had not referred to the treatment center during the scorpion bite and had not presented with systematic symptoms; she also had not received an anti-venom. At emergency admission, the patient's vital signs were within normal range (BP:130/70mmHg, HR: 78bpm in the sinus rhythm, RR: 21 bpm, T:37.1ºC oral temperature). The patient had no past history of systemic diseases such as hypertension, diabetes and coagulative disorders. External eye examination showed the site of scorpion bite had redness and swelling ([Figure 1](#F1){ref-type="fig"}). Visual acuity was 4/10 in the right eye and 10/10 in the left eye. No relative afferent pupillary defect was detected. There was no disturbance in the extraocular muscle function. The slit lamp examination had no remarkable finding. The examination of the fundus showed retinal edema and retinal hemorrhage in the superior arcade of the macula. The fundus photograph showed evidence of occlusion in the superior retinal vein branch and multiple areas of intra- and pre-retinal hemorrhages ([Figure 2](#F2){ref-type="fig"}). 

![External eye examination showed the site of scorpion bite had redness and swelling](bet-7-076-g001){#F1}

![Fundus photograph shows occlusion in superior retinal vein branch and multiple areas of Intra- and pre-retinal hemorrhages. SD-OCT shows extracellular retinal edema and increased retinal thickness](bet-7-076-g002){#F2}

Spectral Domain Optical Coherence Tomography (SD; OCT) revealed that retinal thickness had increased in the temporal side and there were some hyper-reflective dots in the thickness of the retina in favor of retinal hemorrhage. Increase in the thickness of the retinal layers was evident in the extracellular edema subsequent to retinal vein occlusion ([Figure 2](#F2){ref-type="fig"}) Hence, management of BRVO was done with intravitreal bevacizumab in the early phase (1 week later). Intravitreal injection of bevacizumab resolved the macular edema and vision recovery was achieved 2 weeks after the injection.

Discussion
==========

Scorpion bites are reported in different parts of Iran \[[@B5]\]. There are two popular scorpion families in Iran: Hemiscorpiidae and Buthidae \[[@B6]\]. Clinical signs and symptoms are not precisely determined for scorpion envenomation \[[@B5]\]. Most common clinical manifestations of scorpion bites are presented in the vital organs such as the Central Nervous System (CNS), Cardiovascular System (CVS), respiratory system, coagulation cascade, and endocrine system \[[@B2], [@B5]-[@B7]\].There are few reports of ophthalmic manifestations of the scorpion bite. [Table 1](#T1){ref-type="table"} shows the summary of the reported ophthalmic manifestation cases following scorpion bite. Ophthalmic involvements are mostly described as blindness. Two cases reported blindness as a consequence of brain infarction which leads to cortical blindness. One case presented with blindness without other neurologic symptoms after several episodes of the scorpion bite \[[@B3], [@B8], [@B9]\].

###### 

Summary of the reported ophthalmologic manifestation cases following scorpion bite

  **Author**                                         **Year**   **Country**    **Age**   **Sex (M** [a](#TFN1){ref-type="table-fn"} **/F** [b](#TFN2){ref-type="table-fn"} **)**   **Scorpion**                         **ABP** [c](#TFN3){ref-type="table-fn"} **(mmHg)**   **Ocular Manifestation**     **Outcome**
  -------------------------------------------------- ---------- -------------- --------- ----------------------------------------------------------------------------------------- ------------------------------------ ---------------------------------------------------- ---------------------------- ---------------------------------------
  **Roussel\[** [@B3] **\]**                         1986       French         6         NR[c](#TFN3){ref-type="table-fn"}                                                         Leiurusquinquestriatus               NR [d](#TFN4){ref-type="table-fn"}                   Transient blindness          Complete Recovery
  **Annobil** ***et.al*** **., \[** [@B13] **\]**    1991       Saudi Arabia   3         M                                                                                         Nebo hierochonticus                  NR [d](#TFN4){ref-type="table-fn"}                   Transient Blindness          resorption of the retinal haemorrhage
  **Thacker \[** [@B14] **\]**                       2002       India          17        M                                                                                         Buthus tumulus                       120/70                                               Bilateral Optic Neuropathy   Left side Persistent Blindness
  **Sadeghian\[** [@B15] **\]**                      2003       Iran           54        F                                                                                         MesobuthusEupeus                     NR [d](#TFN4){ref-type="table-fn"}                   Transient ophthalmoplegia    Complete Recovery
  **Sengupta** ***et. al*** **., \[** [@B8] **\]**   2009       French         40        F                                                                                         NR [d](#TFN4){ref-type="table-fn"}   90/60                                                Blindness                    Cerebral blindness
  **Delma\[** [@B10] **\]**                          2012       Algeria        24        F                                                                                         NR [d](#TFN4){ref-type="table-fn"}   90/50                                                Blindness                    Persistent Blindness
  **Hamid**                                          2018       Iran           45        F                                                                                         Mesobuthus Eupeus                    130/70                                               Macular BRVO                 Complete Vision Recovery

M: Male;

F: Female;

ABP: Arterial Blood Pressure at hospital presentation;

NR: not reported

The authors mentioned several hypotheses to explain the blindness such as the direct effect of the scorpion venom on the optic nerve and hypersensitivity reaction to the scorpion venom or anti-venom \[[@B10]\]. In the present case, the patient did not receive an anti-venom. Another case presented with ophthalmoplegia after scorpion bite in the eyebrow \[[@B4]\]. Previous cases of the scorpion bite with ophthalmic manifestations seemed to have no direct effect on the orbital circulation. To the best of our knowledge, we here present a case of scorpion bite presented with the rare manifestation of macular BRVO two days after being bitten in the eyebrow on the same side. Coagulative disorders such as Disseminated Intravascular Coagulation (DIC) is one of the complications developed after scorpion bite \[[@B5]\]. In this case, findings are in favor of localized intravascular coagulation which caused an occlusion in the branch of the retinal vein. Despite previous cases, decreased vision is related to localized stroke happened in ophthalmic circulation, affecting the ocular vascular directly without the accompaniment of other neurologic or vascular accidents in other organs. The scorpion venom activates coagulation cascade through its low molecular weight polypeptides in different pathways. The main messengers for induction of the coagulation and complement cascade are cytokines such as endothelin and neuropeptide Y \[[@B11]\].The mechanisms indicated explain the reported case.

Based on previous studies, the first line treatment for acute BRVO is anti-VEFG treatment. Anti-VEFG treatment had promising results in the macular edema and visual acuity improvement. Regardless of the cause of the retinal vein occlusion, this treatment was considered for this patient and the result was encouraging \[[@B12]\]. This is the first case presented as macular BRVO due to scorpion bite. Given the age, medical history, and health status of the patient, other causes of vascular accident with exclusive ophthalmic presentation were unlikely to be the case.

In conclusion, in endemic regions it should be kept in mind that less dangerous scorpion species might present with local non-fatal effects, due to the characteristics of the scorpion toxin. As mentioned in this case quick action in treating eye problems is very helpful with good prognosis.
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